Wednesday, January 23, 2013 Tuesday, January 22, 2013- Impax Laboratories Falls as FDA Rejects Parkinson’s Drugat Bloomberg (Tue, Jan 22)
- One Biotech Pony, Lots of Tricksat Motley Fool (Tue, Jan 22)
- Glaxo Plaintiff Lawyers Settle Dispute Over $143 Millionat Bloomberg (Tue, Jan 22)
- Trials Of Niacin And Atrial Fibrillation Device Will Headline American College Of Cardiology Programat Forbes (Tue, Jan 22)
- 3 Pharma Stocks That Could Be Good For Youat Forbes (Tue, Jan 22)
- J&J Beats on EPS but Guidance LagsZacks (Tue, Jan 22)
- Claman's Davos Notebook: Who to Expect at Davosat Fox Business (Tue, Jan 22)
- J&J: Investors Sick Over Low 2013 Profit Forecast, Despite Rebound In Q4at Forbes (Tue, Jan 22)
- Special interests gather for own inaugural partiesAP (Tue, Jan 22)
Monday, January 21, 2013 Saturday, January 19, 2013 Friday, January 18, 2013Add MRK News to My Yahoo!  | |
|